Pharmacol Rep: Difference between revisions
From Bioblast
m (moved Pharmacol. Rep. to Pharmacol Rep) |
No edit summary Β |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{Journal}} | {{Journal | ||
|Title=[http://www.if-pan.krakow.pl/pjp/ Pharmacological Reports] | |||
}} | |||
Latest revision as of 16:45, 22 March 2017
| Journal title and website | Pharmacological Reports |
|---|
Publications
| Reference | Published | View | |
|---|---|---|---|
| Bociaga-Jasik 2013 Pharmacol Rep | BociΔ ga-Jasik M, Polus A, GΓ³ralska J, Czech U, Gruca A, Sliwa A, Garlicki A, Mach T, DembiΕska-KieΔ A (2013) Metabolic effects of the HIV protease inhibitor β saquinavir in differentiating human preadipocytes. Pharmacol Rep 65:937-50. | 2013 | PMID: 24145088 Open Access |
| Chmielewska 2011 Pharmacol Rep | Chmielewska L, MaliΕska D (2011) Cytoprotective action of the potassium channel opener NS1619 under conditions of disrupted calcium homeostasis. Pharmacol Rep 63: 176-183. | 2011 | PMID:21441626 |
